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Dear Editor,
Large-scale surveillance for severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2),
the pathogen for coronavirus disease 19 (COVID-19) is
an important strategy for preventing the second wave of
the disease [1]. Group testing of pooled specimens to
detect for SARS-CoV-2 has been shown to be an
effective strategy to conserve resources and to
substantially increase testing capacity [2,3]. In order to
reveal the importance of group testing for COVID-19,
the FDA issued a statement on facilitating diagnostic
test availability for asymptomatic testing and pool
testing on June 16, 2020 [4]. To our knowledge, this is
the first study to determine the cost effectiveness of
SARS-CoV-2 sample pooling. A total of 4,630
nasopharyngeal specimens were collected from both
asymptomatic and symptomatic patients suspected to
have COVID-19. Based on our proof-of-concept study
[2], these specimens were randomly pooled into groups
of 5 specimens per pool for a total of 926 pools. RNA
from each pool was extracted using the QIAGEN EZ1
Virus Mini Kit v2.0 (QIAGEN, Germantown, MD)
with subsequent RT-PCR testing with the CDC EUA
nCoV-2019 assay. RT-PCR assays were performed
using Applied Biosystems 7500 Fast Dx Real-time PCR
analyzer as recommended by the manufacturer.
Specimens within positive pools were individually retested using the same procedure. Costs for reagents,
consumables, and labor were subsequently compared
between pool testing and individual testing using
standard costs for supplies, reagents, and per hour labor
plus benefits (Table 1). A total of 303 pools
(representing 1,515 patients) were positive that

contained 455 specimens with SARS-CoV-2
(represented a positive rate of 9.8%). All positive pools
had at least one individual specimen that was identified
as positive. In this pooling process, 2,441 tests were
performed (926 represented the original pools and
1,515 represented individuals from split pools). This
compares with 4,630 tests if all were tested
individually, resulting in a saving of 2,189 tests
(47.3%).
The cost of pool testing to include repeat testing of
individual specimens from positive pools was $45,787
compared to $80,921 for individual tests resulting in a
cost savings of $35,134 (43.4%) (Table 1). The total
labor cost required for pooling tests was $10,124
compared to $13,277 for individual testing with saving
of $3,153 (23.7%). No additional technologists were
required to conduct SARS-CoV-2 testing when a
pooling approach was implemented. All reporting of
pool test results and backtracking positive pools to split
for individual testing were done manually.
These data showed that specimen pooling for
SARS-CoV-2 at a positive rate of 9.8% resulted in a
savings of 47.3% on the use of reagents and 23.7% on
labor. In a low prevalence population where large
numbers of asymptomatic individuals are tested for
surveillance, the cost savings would even be greater [2].
For example, with a positive rate of 1% and an optimal
pooling size of 11 samples, there would be an
approximate 80% reduction in test volume with a
similar cost and time savings [2]. Anticipations are that
large-scale screening of asymptomatic populations such
as students, athletes, and military personnel, will be a
common practice to monitor for COVID-19. The
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optimal group size, which is dependent on the COVID19 prevalence rate, the sensitivity and specificity of the
assay, and on the pooling algorithm (a 2-stage or 3stage algorithm), will be important to determine [2,5].
The cost and time saving of pooling will also vary based
on the extraction and RT-PCR methods used to detect
SARS-CoV-2. In addition, savings will also depend on
the reporting process used and whether the tracking of
positive pools for individual retesting is automated or
manual.
In conclusion, diagnostic testing to identify people
with COVID-19 for quarantine and contact tracing will
continue to be needed to control future outbreaks of
SARS-CoV-2 in the population. Large-scale
surveillance will require increased amounts of reagents
and supplies, which currently are limited. This study
was conducted as a proof-of-concept to show the
savings of group testing at one institution in a localized
geographical location. Further studies are needed to
evaluate the impact of group testing using different
RNA extraction methods and PCR platforms for
optimal diagnostics. In addition, other issues will need
to be considered such as changes required to the
laboratory information management system (LIMS) for
reporting, the cost involved in performing verification
testing as defined by the FDA to add a pooling
procedure to laboratory testing to meet regulatory
standards, and changes to the work flow in the
laboratory.
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Table 1. Comparison of costs between individual compared to pooled specimens for the detection of SARS-CoV-2.
Total cost
Category
Individual a
Pooled b
Reagents and Consumables
RNA extraction c

$ 42,503

$ 22,408

RT-PCR

$ 25,141

$ 13.255

d

Labor e
Set-up for original pools f

$0

$ 1,128

RNA extraction g

$ 6,035

$ 3,181

RT-PCR

$ 3,017

$ 1,590

h
i

Reporting

$ 4,225

$ 4,225

(Total costs for labor)

($13,277)

($10,124)

Total cost

$ 80,921

$ 45,787

Based-on testing 4,630 individual specimens; b Based-on testing 2,441 individual specimens (926 original pools and 1515 individuals from split pools); c Based
on an average kit/unit cost of $9.18 for RNA extraction kit, AVL buffer, and consumables; d Based on an average cost of $5.43 for RT-PCR mix, primers/probes,
and consumables; e The average technologist salary plus benefits used for this analysis was $36.50 per hour; f Time required to prepare 926 pools (5 specimens
per pool) was calculated at 30.9 hours; g Time required was based on 14 samples per extraction run at 0.5 hours; h Time required was based on 28 samples per
PCR run at 0.5 hours; i Time required for reporting was determined to be 1.5 minutes per specimen.
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